4.09 Problems with the VISION Trial & Stool Transplant Plus Nivo for Metastatic Melanoma

from Plenary Session - inactive due to federal service · host Vinay Prasad, MD MPH

Today we have two short monologues for you on recent papers. The first, by popular request, is the problems with the VISION trial, which treated metastatic castration-resistant prostate cancer with lutetium-177–PSMA-617 (Lu-177–PSMA-617) radioligand therapy and standard of care. The second is on the paper recently published in Science titled "Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients". Fecal transplant: doi.org/10.1126/science.abb5920 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

Episode metadata supplied by the publisher feed · Published Jul 23, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

4.09 Problems with the VISION Trial & Stool Transplant Plus Nivo for Metastatic Melanoma

0:00 26:38

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Plenary Session - inactive due to federal service?

This episode is 26 minutes long.

When was this Plenary Session - inactive due to federal service episode published?

This episode was published on July 23, 2021.

Can I download this Plenary Session - inactive due to federal service episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!